|
STK11IP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.260300E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.936300E-02 |
| Normal-vs-Stage2 |
9.970000E-02 |
| Normal-vs-Stage3 |
7.540000E-01 |
| Normal-vs-Stage4 |
9.716600E-01 |
| Stage1-vs-Stage2 |
4.880800E-01 |
| Stage1-vs-Stage3 |
1.782760E-01 |
| Stage1-vs-Stage4 |
2.412000E-01 |
| Stage2-vs-Stage3 |
1.502600E-01 |
| Stage2-vs-Stage4 |
1.297030E-01 |
| Stage3-vs-Stage4 |
8.017600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.650100E-02 |
| Normal-vs-AfricanAmerican |
8.164300E-02 |
| Normal-vs-Asian |
6.602000E-01 |
| Caucasian-vs-AfricanAmerican |
8.128800E-01 |
| Caucasian-vs-Asian |
6.852600E-01 |
| AfricanAmerican-vs-Asian |
6.425400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.530200E-02 |
| Normal-vs-Female |
1.793960E-02 |
| Male-vs-Female |
8.880400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.136400E-01 |
| Normal-vs-Extreme_Weight |
4.647000E-01 |
| Normal-vs-Obese |
1.164990E-01 |
| Normal-vs-Extreme_Obese |
3.632300E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.827600E-01 |
| Normal_Weight-vs-Obese |
8.895000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.388600E-01 |
| Extreme_Weight-vs-Obese |
3.255000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.680500E-02 |
| Obese-vs-Extreme_Obese |
2.011400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.563400E-03 |
| Normal-vs-Age(41-60Yrs) |
2.249600E-02 |
| Normal-vs-Age(61-80Yrs) |
1.546780E-01 |
| Normal-vs-Age(81-100Yrs) |
5.570400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.323200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.650100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.783700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.934170E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.525900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.312220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.555580E-03 |
| Normal-VS-Type2 PRCC |
7.501700E-02 |
| Normal-VS-KIRP CIMP |
5.292200E-01 |
| Normal-VS-Unclassified PRCC |
2.602700E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.54309906466688E-11 |
| Type1 PRCC-VS-KIRP CIMP |
2.077800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.195400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.330300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.88969999995281E-06 |
| KIRP CIMP-VS-Unclassified PRCC |
1.439610E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.178200E-01 |
| Normal-vs-N1 |
4.449200E-01 |
| Normal-vs-N2 |
3.356400E-01 |
| N0-vs-N1 |
5.525800E-01 |
| N0-vs-N2 |
4.387600E-01 |
| N1-vs-N2 |
9.792600E-01 |
|
|
